Acessibilidade e conforto de leitura

Tamanho do texto

Modo claro/escuro

Espaçamento vertical entre linhas

Problemas para usar nosso site?
Contato

Pr Frank Holz

In esta página

Informações do membro

Pr Frank Holz

Representante

Alemanha

Time

Dr Philipp Herrmann

Alemanha

CPMS e medicina digital (TWG10), diagnóstico genético (TWG6), pesquisa (TWG8), doenças oculares raras da retina (WG1)
Ver mais

Centro de saúde

O departamento de doenças oculares cobre toda a gama de operações oftalmológicas cirúrgicas e oferece atendimento de todos os exames e exames de última geração...

Contacto

University of Bonn, Germany

Ernst-Abbe-Strasse 2
53127 Bonn
Germany

Ensaios clínicos

NCT05698316). Ativo, não recrutando

A Collaborative Resource of Heidelberg Multimodal Imaging of Intermediate and Early Atrophic AMD Cases to Study Prediction of Disease Progression: (INTERCEPT-AMD)

Observacional
Veja o julgamento
veja a ficha

NCT01835002). Efetuado

This is a single-arm open label interventional safety trial with RP patients, who receive weekly TES for 6 months on 1 eye followed by observation for another 6 months without stimulation. The primary outcome measure is safety, indicated by the frequency and severity of adverse events.

Intervencionista
Veja o julgamento
veja a ficha
2018-001496-20 Recrutamento, Ativo

Clinical trials for A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral Soraprazan in Stargardt Phase 2, disease SMR-3438, Katairo

Intervencionista
Veja o julgamento
veja a ficha
NCT03584165). Inscrições por convite

A Long-term Follow-up Study to Evaluate the Safety and efficacy of Retinal Gene Therapy in Subjects with choroideremia treated previously with Adeno-Associated Viral Vector Encoding Rab Escort Protein-1 (AAV2-REP1) in an Antecedent Study.

Intervencionista
Veja o julgamento
veja a ficha
NCT02410122). Efetuado

The Natural History of the Progression of Atrophy Secondary to Stargardt Disease Type 4: PROM1-Related Macular Dystrophy (ProgStar-4).

Observacional
Veja o julgamento
veja a ficha
NCT03364153). Efetuado

A Phase 2b Randomized, Double-masked, Controlled Trial to Establish the Safety and Efficacy of Zimura™ (Complement C5 Inhibitor) Compared to Sham in Subjects With Autosomal Recessive Stargardt Disease

Intervencionista
Veja o julgamento
veja a ficha
NCT04435366). Efetuado

A Phase 3 Multicenter, Randomized, Double Masked, Sham- Controlled Clinical Trial to Assess the Safety and Efficacy of Intravitreal Administration of Zimura (Complement C5 Inhibitor) in Patients With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Intervencionista
Veja o julgamento
veja a ficha
NCT05384249). Ativo, não recrutando

A Phase 2b Pivotal Study to Evaluate the Efficacy and Safety of Izokibep in Subjects With Non-infectious, Intermediate-, Posterior- or Pan-uveitis

Intervencionista
Veja o julgamento
veja a ficha
NCT04770545). Efetuado

A Phase 3, Open-Label, Multicenter, Extension Study to Evaluate the Long-Term Safety and Efficacy of Pegcetacoplan in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Intervencionista
Veja o julgamento
veja a ficha
DRKS00023562 Recrutamento, Ativo

Evaluation of the effectiveness of transcorneal electrostimulation in patients with retinitis pigmentosa - a multicenter, prospective, randomized, controlled and double-blind study on behalf of the G-BA

Intervencionista
Veja o julgamento
veja a ficha
NCT06070467). Não recrutando

Holistic Mixed Approaches to Capture the Real Life of Children With Rare Eye Diseases

Observacional
Veja o julgamento
veja a ficha

A multi-national, multi-centre, double-masked, placebo-controlled proof of concept trial to evaluate the safety and efficacy of oral soraprazan in Stargardt disease

Intervencionista
Veja o julgamento
veja a ficha